Cancer Institute A national cancer institute
designated cancer center

Douglas W. Blayney

Publication Details

  • Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.

    Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. J Clin Oncol. 2008; 26 (34): 5553-60

    To describe the frequency of chemotherapy use for hormone receptor (HR)-positive, lymph node (LN)-negative breast cancer from 1997 to 2004 at eight National Comprehensive Cancer Network institutions, to explore whether chemotherapy use varied over time and between institutions, and to identify factors associated with the decision to forego chemotherapy.

    PubMedID: 18955448

Stanford Medicine Resources:

Footer Links: